Literature DB >> 32389458

Factors Associated With Receipt of Partial Nephrectomy or Minimally Invasive Surgery for Patients With Clinical T1a and T1b Renal Masses: Implications for Regionalization of Care.

Joshua Sterling1, Zorimar Rivera-Núñez2, Hiren V Patel1, Nicholas J Farber1, Sinae Kim3, Kushan D Radadia1, Parth K Modi1, Sharad Goyal4, Rahul Parikh4, Robert E Weiss1, Isaac Y Kim1, Sammy E Elsamra1, Thomas L Jang1, Eric A Singer5.   

Abstract

PURPOSE: To identify factors associated with receipt of partial nephrectomy (PN) and minimally invasive surgery (MIS) in patients with clinical T1 renal cell carcinoma (RCC) using the National Cancer Data Base (NCDB).
METHODS: We queried the NCDB from 2010 to 2014 identifying patients treated surgically for cT1a-bN0M0 RCC. Logistic regression was used to examine associations between socioeconomic, clinical, and treatment factors, and receipt of MIS or PN within the T1 patient population.
RESULTS: Our cohort included 69,694 patients (cT1a, n = 44,043; cT1b, n = 25,651). For cT1a tumors, 70% of patients received PN and 65% underwent MIS. For cT1b tumors, 32% of patients received PN and 62% underwent MIS. cT1a and cT1b patients with household income < $62,000, without private insurance, and treated outside academic centers were less likely to receive MIS or PN. cT1a patients traveling > 31 miles were more likely to undergo MIS. For both cT1a/b, the farther a patient traveled for treatment, the more likely a PN was performed.
CONCLUSION: Data showed an increase in utilization of MIS and PN from 2010 to 2014. However, patients in the lowest socioeconomic groups were less likely to travel and were more likely to receive more invasive treatments. On the basis of these findings, additional research is needed into how regionalization of RCC surgery affects treatment disparities.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Disparity; Nephron-sparing surgery; Renal cell carcinoma; Small renal masses; Travel

Year:  2020        PMID: 32389458      PMCID: PMC7502425          DOI: 10.1016/j.clgc.2020.03.011

Source DB:  PubMed          Journal:  Clin Genitourin Cancer        ISSN: 1558-7673            Impact factor:   2.872


  37 in total

1.  Trends in Renal-Cell Carcinoma Incidence and Mortality in the United States in the Last 2 Decades: A SEER-Based Study.

Authors:  Anas M Saad; Mohamed M Gad; Muneer J Al-Husseini; Inas A Ruhban; Mohamad Bassam Sonbol; Thai H Ho
Journal:  Clin Genitourin Cancer       Date:  2018-10-11       Impact factor: 2.872

Review 2.  Comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysis.

Authors:  Simon P Kim; R Houston Thompson; Stephen A Boorjian; Christopher J Weight; Leona C Han; M Hassan Murad; Nathan D Shippee; Patricia J Erwin; Brian A Costello; George K Chow; Bradley C Leibovich
Journal:  J Urol       Date:  2012-05-14       Impact factor: 7.450

3.  Ethnic disparities in renal cell carcinoma: An analysis of Hispanic patients in a single-payer healthcare system.

Authors:  Alfredo Suarez-Sarmiento; Xiaopan Yao; Jonathan N Hofmann; Jamil S Syed; Wei K Zhao; Mark P Purdue; Wong-Ho Chow; Douglas Corley; Brian Shuch
Journal:  Int J Urol       Date:  2017-09-15       Impact factor: 3.369

4.  The Impact of Surgeon Volume on Perioperative Outcomes and Cost for Patients Receiving Robotic Partial Nephrectomy.

Authors:  Yash S Khandwala; In Gab Jeong; Jae Heon Kim; Deok Hyun Han; Shufeng Li; Ye Wang; Steven L Chang; Benjamin I Chung
Journal:  J Endourol       Date:  2017-06-21       Impact factor: 2.942

5.  Association of race and margin status among patients undergoing robotic partial nephrectomy for T1 renal cell carcinoma: Results from a population-based cohort.

Authors:  Victor S Chen; Robert Abouassaly; Christopher M Gonzalez; Alexander Kutikov; Marc C Smaldone; Neal J Meropol; Sarah P Psutka; Stephen B Williams; Rebecca O'Malley; Hillary M Sedlacek; Simon P Kim
Journal:  Urol Oncol       Date:  2017-08-07       Impact factor: 3.498

6.  Can partial nephrectomy provide equal oncological efficiency and safety compared with radical nephrectomy in patients with renal cell carcinoma (≥4cm)? A propensity score-matched study.

Authors:  Hakmin Lee; Jong Jin Oh; Seok Soo Byun; Chang Wook Jeong; Cheol Kwak; Byong Chang Jeong; Seong Soo Jeon; Hyun Moo Lee; Han-Yong Choi; Seong Il Seo
Journal:  Urol Oncol       Date:  2017-03-09       Impact factor: 3.498

7.  The Association between Mortality and Distance to Treatment Facility in Patients with Muscle Invasive Bladder Cancer.

Authors:  Stephen Ryan; Emily C Serrell; Patrick Karabon; Gregory Mills; Moritz Hansen; Matthew Hayn; Mani Menon; Quoc-Dien Trinh; Firas Abdollah; Jesse D Sammon
Journal:  J Urol       Date:  2017-10-10       Impact factor: 7.450

8.  Impact of hospital case volume on testicular cancer outcomes and practice patterns.

Authors:  Solomon L Woldu; Justin T Matulay; Timothy N Clinton; Nirmish Singla; Laura-Maria Krabbe; Ryan C Hutchinson; Arthur Sagalowsky; Yair Lotan; Vitaly Margulis; Aditya Bagrodia
Journal:  Urol Oncol       Date:  2017-09-19       Impact factor: 3.498

9.  Benefit in regionalization of care for patients treated with nephrectomy: a Nationwide Inpatient Sample.

Authors:  Andreas Becker; Marco Bianchi; Jens Hansen; Zhe Tian; Shahrokh F Shariat; Ioana Popa; Paul Perrotte; Quoc-Dien Trinh; Pierre I Karakiewicz; Maxine Sun
Journal:  World J Urol       Date:  2014-02-11       Impact factor: 4.226

Review 10.  Treatment of renal cell carcinoma: Current status and future directions.

Authors:  Pedro C Barata; Brian I Rini
Journal:  CA Cancer J Clin       Date:  2017-09-29       Impact factor: 508.702

View more
  2 in total

1.  Impacts of Neighborhood Characteristics and Surgical Treatment Disparities on Overall Mortality in Stage I Renal Cell Carcinoma Patients.

Authors:  Alejandro Cruz; Faith Dickerson; Kathryn R Pulling; Kyle Garcia; Francine C Gachupin; Chiu-Hsieh Hsu; Juan Chipollini; Benjamin R Lee; Ken Batai
Journal:  Int J Environ Res Public Health       Date:  2022-02-12       Impact factor: 3.390

2.  Delaying surgery for clinical T1b-T2bN0M0 renal cell carcinoma: Oncologic implications in the COVID-19 era and beyond.

Authors:  Arnav Srivastava; Hiren V Patel; Sinae Kim; Brian Shinder; Joshua Sterling; Alexandra L Tabakin; Charles F Polotti; Biren Saraiya; Tina Mayer; Isaac Y Kim; Saum Ghodoussipour; Hiten D Patel; Thomas L Jang; Eric A Singer
Journal:  Urol Oncol       Date:  2020-10-20       Impact factor: 3.498

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.